Literature DB >> 18855057

Day-case laparoscopic Nissen fundoplication.

C D Jensen1, A D Gilliam, L F Horgan, S Bawa, S E Attwood.   

Abstract

INTRODUCTION: Nissen fundoplication has been performed laparoscopically for over 15 years, being associated with shorter hospital stay and fewer complications than conventional open surgery with good long-term outcomes. Day-case laparoscopic Nissen fundoplication (LNF) is rarely performed in the UK and most series in the literature report length of stay >2 days.
METHODS: The objective of this study was to examine the safety and efficacy of day-case LNF. The clinical records of all patients undergoing LNF under the care of three surgeons in a district general hospital (DGH) during a 5-year period (January 2003 to December 2007) were reviewed to examine length of stay, complications, length of procedure, grade of operating surgeon and symptoms on follow-up.
RESULTS: One hundred thirteen day-case LNFs were recorded in this series. Day-case LNF patients had median age of 45 years (range 20-68 years, 65% (64.6%) male) and 98% were American Society of Anesthesiologists (ASA) grade I or II. Twenty-one cases (19%) were performed by higher surgical trainees. Median operative time was 54 minutes (range 25-120 min). Only one perioperative complication (port-site bleed) occurred, treated without prolonging length of stay. The proportion of all LNF performed as day cases increased from 8% to 52% during the study period. Median operative time has significantly reduced from the first 20 consecutive LNF cases to the latest 20 cases [65 min (range 40-120 min) versus 48 min (range 25-72 min); p = 0.037]. At follow-up (median 7 weeks, range 2-31 weeks) 82% of patients had improvement in all presenting symptoms. Eight patients had postoperative complications [wound infection (n = 2), persistent regurgitation requiring laparoscopic division of a gastric band adhesion (n = 1), dysphagia (n = 5 with two patients requiring redo partial fundoplication and one patient requiring dilatation) and there were no conversions to open surgery.
CONCLUSION: Day-case LNF is safe and effective for treating selected patients with gastroesophageal reflux disease (GERD) in a DGH. The proportion of day-case LNFs is increasing in our unit. Half of the LNFs in a DGH can be done as day cases. Experience is associated with a significant reduction in operative time.

Entities:  

Mesh:

Year:  2008        PMID: 18855057     DOI: 10.1007/s00464-008-0178-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  25 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  [A simple operation for control of reflux esophagitis].

Authors:  R NISSEN
Journal:  Schweiz Med Wochenschr       Date:  1956-05-18

3.  Laparoscopic antireflux surgery at an outpatient surgery center.

Authors:  C R Finley; J B McKernan
Journal:  Surg Endosc       Date:  2001-05-11       Impact factor: 4.584

4.  Feasibility of 23-hour hospitalization after laparoscopic fundoplication.

Authors:  P K Narain; J M Moss; E J DeMaria
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2000-02       Impact factor: 1.878

Review 5.  Systematic review of day-case laparoscopic Nissen fundoplication.

Authors:  Raphael Ng; Emma J Mullin; Guy J Maddern
Journal:  ANZ J Surg       Date:  2005-03       Impact factor: 1.872

6.  Result of 310 consecutive patients undergoing laparoscopic Nissen fundoplication as hospital outpatients or at a free-standing surgery center.

Authors:  S Ray
Journal:  Surg Endosc       Date:  2002-12-20       Impact factor: 4.584

7.  Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease.

Authors:  R A Hinder; C J Filipi; G Wetscher; P Neary; T R DeMeester; G Perdikis
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

8.  Outpatient laparoscopic cholecystectomy.

Authors:  O Mjåland; J Raeder; V Aasboe; E Trondsen; T Buanes
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

9.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

10.  Laparoscopic Nissen fundoplication--a curative, safe, and cost-effective procedure for complicated gastroesophageal reflux disease.

Authors:  D D Coster; W H Bower; V T Wilson; D A Butler; S C Locker; R T Brebrick
Journal:  Surg Laparosc Endosc       Date:  1995-04
View more
  6 in total

1.  Same day discharge for benign laparoscopic hiatal surgery: a feasibility analysis.

Authors:  Juan Carlos Molina; Ana María Misariu; Ioana Nicolau; Jonathan Spicer; David Mulder; Lorenzo E Ferri; Carmen L Mueller
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

Review 2.  Ambulatory laparoscopic fundoplication for gastroesophageal reflux disease: a systematic review.

Authors:  Christophe Mariette; Patrick Pessaux
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

3.  A debate on the roles of antireflux surgery and long term acid suppression in the management of gastro-oesophageal reflux disease.

Authors:  Stephen E Attwood; Jean Paul Galmiche
Journal:  Frontline Gastroenterol       Date:  2011-04-01

Review 4.  Systematic review of same-day laparoscopic adjustable gastric band surgery.

Authors:  Harun Thomas; Sanjay Agrawal
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

5.  Variation in laparoscopic anti-reflux surgery across England: a 5-year review.

Authors:  Thomas R Palser; Adam Ceney; Alex Navarro; Simon Swift; David J Bowrey; Ian J Beckingham
Journal:  Surg Endosc       Date:  2018-01-24       Impact factor: 4.584

Review 6.  A systematic review of the effects of residency training on patient outcomes.

Authors:  Renée M van der Leeuw; Kiki M J M H Lombarts; Onyebuchi A Arah; Maas Jan Heineman
Journal:  BMC Med       Date:  2012-06-28       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.